Skip to content

Clinical trials

Completed Phase 3 Post-Acute COVID-19 Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Phase: Phase 3 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20212
20222
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cardresearch1
Materia Medica Holding1
NPO Petrovax1
RDC Clinical Pty Ltd1
Southwest College of Naturopathic Medicine1
University of Mississippi Medical Center1
University of Zurich1
Wuerzburg University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome8
COVID-192
Fatigue Syndrome, Chronic2
Disease1
Fatigue1
Fibrosis1
Inflammation1
Lung Diseases1
Lung Diseases, Interstitial1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.